Our results demonstrate that ADC inhibits TGF-β1-induced changes in EMT markers via down-regulation of Smad2/Smad3 signaling cascades as well as inhibits matrix degradation, migration, and invasion of breast cancer cells through the inhibition of β-catenin signaling pathway. Here, SMAD2 is linked to breast carcinoma.